Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?

Saved in:
Bibliographic Details
Title: Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?
Authors: Frezza, Anna Maria1,2 a.frezza@unicampus.it, Beale, Tim1 tim.beale@uclh.nhs.uk, Bomanji, Jamshed1 jamshed.bomanji@uclh.nhs.uk, Jay, Amrita1 amrita.jay@uclh.nhs.uk, Kalavrezos, Nicholas1 Nicholas.kalavrezos@uclh.nhs.uk, Dileo, Palma1 palma.dileo@uclh.nhs.uk, Whelan, Jeremy1 jeremy.whelan@uclh.nhs.uk, Strauss, Sandra J.1 s.strauss@ucl.ac.uk
Source: BMC Cancer. 2014, Vol. 14 Issue 1, p1-16. 16p.
Database: Academic Search Ultimate
Description
ISSN:14712407
DOI:10.1186/1471-2407-14-23